As diabetes and obesity are projected to be epidemic in the emerging markets where westernisation has become mainstream, Synexus are committed to recruiting and retaining patients for biopharmaceutical and medical device and diagnostic studies in both these emerging markets and in more traditional areas. With successful trials ranging from diabetic nephropathy to diabetic neuropathy, with diabetics taking specific medications, to diabetics who must have had a CV event, Synexus can help you reach smarter clinical decisions faster.

Areas of expertise include

  • Chronic inflammation
  • Diabetes companion devices
  • Diabetes complications
  • Diabetes/cardiovascular
  • Diabetes/obesity
  • Diabetic foot ulcers
  • Diabetic gastroparesis
  • Diabetic nephropathy
  • Diabetic neuropathy
  • Diabetic retinopathy
  • Erectile dysfunction
  • Macrovascular disease
  • Macular edema
  • Type 1 diabetes
  • Type 2 diabetes

Patients recruited

12,800

to diabetic studies

Studies performed

671

in diabetic disease